Ascorbate inhibits the carbethoxylation of two histidyl and one tyrosyl residues indispensable for the transmembrane electron transfer reaction of cytochrome b561.
Cytochrome b(561) from bovine adrenal chromaffin vesicles contains two heme B prosthetic groups and transports electron equivalents across the vesicle membranes to convert intravesicular monodehydroascorbate radical to ascorbate. We found previously that treatment of oxidized cytochrome b(561) with diethyl pyrocarbonate caused specific N-carbethoxylation of three fully conserved residues (His88, His161, and Lys85) located at the extravesicular side. The modification lead to a selective loss of the electron-accepting ability from ascorbate without affecting the electron donation to monodehydroascorbate radical [Tsubaki, M., Kobayashi, K., Ichise, T., Takeuchi, F., and Tagawa, S. (2000) Biochemistry 39, 3276-3284]. In the present study, we found that these modifications lead to a drastic decrease of the midpoint potential of heme b at the extravesicular side from +60 to -30 mV. We found further that the O-carbethoxylation of one tyrosyl residue (Tyr218) located at the extravesicular side was significantly enhanced under alkaline conditions, leading to a very slow reduction process of the oxidized heme b with ascorbate. On the other hand, the presence of ascorbate during the treatment with diethyl pyrocarbonate was found to suppress the carbethoxylation of His88, His161, and Tyr218, whereas the modification level of Lys85 was not affected. Concomitantly, the final reduction level of heme b with ascorbate was protected, although the fast reduction phase was not fully restored. These results suggest that the two heme-coordinating histidyl residues (His88 and His161) are also a part of the ascorbate binding site. Tyr218 and Lys85 may have a role in the recognition/binding process for ascorbate and are indispensable for the fast electron transfer reaction.
Takeuchi
F
F
Department of Life Science, Faculty of Science, Himeji Institute of Technology, Kamigoori-cho, Akou-gun, Hyogo 678-1297, Japan.
Kobayashi
K
K
Tagawa
S
S
Tsubaki
M
M
D000818:Animals; D000838:Anions; D001205:Ascorbic Acid / Q000737:chemistry* / Q000378:metabolism; D002417:Cattle; D003573:Cytochrome b Group / Q000037:antagonists & inhibitors* / Q000378:metabolism*; D004047:Diethyl Pyrocarbonate / Q000494:pharmacology; D004579:Electron Transport / Q000187:drug effects; D004791:Enzyme Inhibitors / Q000494:pharmacology; D006639:Histidine / Q000037:antagonists & inhibitors* / Q000378:metabolism; D006868:Hydrolysis; D008565:Membrane Proteins / Q000037:antagonists & inhibitors* / Q000378:metabolism*; D010084:Oxidation-Reduction / Q000187:drug effects; D011199:Potentiometry; D012697:Serine Endopeptidases / Q000378:metabolism; D019032:Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; D014357:Trypsin / Q000378:metabolism; D014443:Tyrosine / Q000037:antagonists & inhibitors* / Q000378:metabolism
D000838:Anions; D003573:Cytochrome b Group; D004791:Enzyme Inhibitors; D008565:Membrane Proteins; C023646:cytochrome b561; D014443:Tyrosine; D006639:Histidine; D012697:Serine Endopeptidases; C028344:glutamyl endopeptidase; D014357:Trypsin; D004047:Diethyl Pyrocarbonate; D001205:Ascorbic Acid